Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acerus Pharmaceuticals Corp (ASP.TO)

Acerus Pharmaceuticals Corp (ASP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,775
  • Shares Outstanding, K 7,708
  • Annual Sales, $ -4,133 K
  • Annual Income, $ -33,817 K
  • 60-Month Beta 0.91
  • Price/Sales 0.67
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ASP.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -3.24
  • Most Recent Earnings $-0.54 on N/A
  • Latest Earnings Date 03/13/23
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2750 +30.91%
on 01/12/23
0.8100 -55.56%
on 12/29/22
-0.5900 (-62.11%)
since 12/23/22
3-Month
0.2750 +30.91%
on 01/12/23
1.8000 -80.00%
on 10/31/22
-1.3400 (-78.82%)
since 10/26/22
52-Week
0.2750 +30.91%
on 01/12/23
10.0000 -96.40%
on 03/22/22
-6.6400 (-94.86%)
since 01/26/22

Most Recent Stories

More News
Acerus: Q3 Earnings Snapshot

Acerus: Q3 Earnings Snapshot

ASP.TO : 0.3600 (unch)
Stocks in play: Acerus Pharmaceuticals Corporation

Reported its financial results for the three-month period ended June 30, 2022. Unless otherwise noted, ...

ASP.TO : 0.3600 (unch)
Acerus Reports Second Quarter 2022 Financial Results

TORONTO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Stocks in play: Acerus Pharmaceuticals Corporation

Has entered into an amending agreement with First Generation Capital Inc., a company affiliated with ...

ASP.TO : 0.3600 (unch)
Acerus Announces Amendments to Loan Facility and Promissory Note Due to Former Serenity Shareholders

TORONTO, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus to Report Q2-2022 Financial Results and Host Investor Call

TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2022 financial and...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Voting Results for the 2022 Annual Meeting

TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced the voting results from...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Stocks in play: Acerus Pharmaceuticals Corporation

Has entered into an amending agreement with First Generation Capital Inc., a company affiliated with ...

ASP.TO : 0.3600 (unch)
Acerus Announces Amendments to Loan Facility

TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)
Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders

TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCD) today announced that it...

ASP.TO : 0.3600 (unch)
ASPCF : 0.2199 (-39.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.3600
2nd Resistance Point 0.3600
1st Resistance Point 0.3600
Last Price 0.3600
1st Support Level 0.3600
2nd Support Level 0.3600
3rd Support Level 0.3600

See More

52-Week High 10.0000
Fibonacci 61.8% 6.2850
Fibonacci 50% 5.1375
Fibonacci 38.2% 3.9899
Last Price 0.3600
52-Week Low 0.2750

See More

Business Summary

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar